Engineering principles of clinical cell-based tissue engineering.

Tissue engineering is a rapidly evolving discipline that seeks to repair, replace, or regenerate specific tissues or organs by translating fundamental knowledge in physics, chemistry, and biology into practical and effective materials, devices, systems, and clinical strategies. Stem cells and progenitors that are capable of forming new tissue with one or more connective tissue phenotypes are available from many adult tissues and are defined as connective tissue progenitors. There are four major cell-based tissue-engineering strategies: (1) targeting local connective tissue progenitors where new tissue is desired, (2) transplanting autogenous connective tissue progenitors, (3) transplanting culture-expanded or modified connective tissue progenitors, and (4) transplanting fully formed tissue generated in vitro or in vivo. Stem cell function is controlled by changes in stem cell activation and self-renewal or by changes in the proliferation, migration, differentiation, or survival of the progeny of stem cell activation, the downstream progenitor cells. Three-dimensional porous scaffolds promote new tissue formation by providing a surface and void volume that promotes the attachment, migration, proliferation, and desired differentiation of connective tissue progenitors throughout the region where new tissue is needed. Critical variables in scaffold design and function include the bulk material or materials from which it is made, the three-dimensional architecture, the surface chemistry, the mechanical properties, the initial environment in the area of the scaffold, and the late scaffold environment, which is often determined by degradation characteristics. Local presentation or delivery of bioactive molecules can change the function of connective tissue progenitors (activation, proliferation, migration, differentiation, or survival) in a manner that results in new or enhanced local tissue formation. All cells require access to substrate molecules (oxygen, glucose, and amino acids). A balance between consumption and local delivery of these substrates is needed if cells are to survive. Transplanted cells are particularly vulnerable. Theoretical calculations can be used to explore the relationships among cell density, diffusion distance, and cell viability within a graft and to design improved strategies for transplantation of connective tissue progenitors. Rational strategies for tissue engineering seek to optimize new tissue formation through the logical selection of conditions that modulate the performance of connective tissue progenitors in a graft site to produce a desired tissue. This increasingly involves strategies that combine cells, matrices, inductive stimuli, and techniques that enhance the survival and performance of local or transplanted connective tissue progenitors.

[1]  E H Burger,et al.  Mechanical loading stimulates the release of transforming growth factor‐β activity by cultured mouse calvariae and periosteal cells , 1995, Journal of cellular physiology.

[2]  M. Magin,et al.  Improved Lumbar Vertebral Interbody Fusion Using rhOP-1: A Comparison of Autogenous Bone Graft, Bovine Hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in Sheep , 2001, Spine.

[3]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[4]  G. Drobny,et al.  Structural studies of biomaterials using double-quantum solid-state NMR spectroscopy. , 2003, Annual review of physical chemistry.

[5]  J. Whitfield,et al.  Parathyroid hormone: an anabolic treatment for osteoporosis. , 2001, Current pharmaceutical design.

[6]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[7]  J. Vacanti,et al.  Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. , 2000, Tissue engineering.

[8]  L. Setton,et al.  Collagen gene expression and mechanical properties of intervertebral disc cell–alginate cultures , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  S. O’Driscoll Current Concepts Review - The Healing and Regeneration of Articular Cartilage* , 1998 .

[10]  Cyril B. Frank,et al.  Current Concepts Review - The Science of Reconstruction of the Anterior Cruciate Ligament* , 1997 .

[11]  O. Böstman,et al.  Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. , 1990, The Journal of bone and joint surgery. British volume.

[12]  Henry C. Vasconez,et al.  Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix , 2001, Pharmaceutical Research.

[13]  J. Wozney,et al.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.

[14]  L. Kunz-Schughart,et al.  Proliferative activity and tumorigenic conversion: impact on cellular metabolism in 3-D culture. , 2000, American journal of physiology. Cell physiology.

[15]  J. Bonadio Tissue engineering via local gene delivery , 2000, Journal of Molecular Medicine.

[16]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  P. Niederer,et al.  A finite element analysis for the prediction of load-induced fluid flow and mechanochemical transduction in bone. , 2003, Journal of theoretical biology.

[18]  C. Verfaillie,et al.  Characterization of Multipotent Adult Progenitor Cells, a Subpopulation of Mesenchymal Stem Cells , 2001, Annals of the New York Academy of Sciences.

[19]  R. Aaron,et al.  Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  P. Hernigou,et al.  Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.

[21]  A. Caplan,et al.  Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.

[22]  N. Dagalakis,et al.  Design of an artificial skin. Part III. Control of pore structure. , 1980, Journal of biomedical materials research.

[23]  J. Wozney,et al.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. , 2000, Journal of biomedical materials research.

[24]  C. Colton,et al.  Effect of External Oxygen Mass Transfer Resistances on Viability of Immunoisolated Tissue a , 1997, Annals of the New York Academy of Sciences.

[25]  N. Garg,et al.  Percutaneous autogenous bone-marrow grafting in congenital tibial pseudarthrosis. , 1995, The Journal of bone and joint surgery. British volume.

[26]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[27]  R. Balderston,et al.  Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 , 2002, Spine.

[28]  C. Huard,et al.  Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. , 1998, Biochemical and biophysical research communications.

[29]  David J. Anderson,et al.  Culture in Reduced Levels of Oxygen Promotes Clonogenic Sympathoadrenal Differentiation by Isolated Neural Crest Stem Cells , 2000, The Journal of Neuroscience.

[30]  Jochen Ringe,et al.  Stem cells for regenerative medicine: advances in the engineering of tissues and organs , 2002, Naturwissenschaften.

[31]  S. O’Driscoll Articular cartilage regeneration using periosteum. , 1999, Clinical orthopaedics and related research.

[32]  C. Boehm,et al.  Age‐ and gender‐related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[33]  R. Burwell Studies in the transplantation of bone. 8. Treated composite homograft-autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. , 1966, The Journal of bone and joint surgery. British volume.

[34]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[35]  Jennifer L. West,et al.  Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .

[36]  H F Sailer,et al.  Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. , 2002, International journal of oral and maxillofacial surgery.

[37]  J. Lee,et al.  Osteoprogenitor cells within skeletal muscle , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  G. Muschler,et al.  Bone cells and matrices in orthopedic tissue engineering. , 2000, The Orthopedic clinics of North America.

[40]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[41]  H. Seeherman,et al.  Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model , 2001, The Journal of bone and joint surgery. American volume.

[42]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[43]  J. Gimble,et al.  The function of adipocytes in the bone marrow stroma: an update. , 1996, Bone.

[44]  G. Mundy,et al.  Optimizing human demineralized bone matrix for clinical application. , 2000, Tissue engineering.

[45]  R. Midura,et al.  Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[46]  A Wilke,et al.  Missing osteoconductive effect of a resorbable PEO/PBT copolymer in human bone defects: a clinically relevant pilot study with contrary results to previous animal studies. , 2000, Journal of biomedical materials research.

[47]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[48]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[49]  W. Davros,et al.  Spine Fusion Using Cell Matrix Composites Enriched in Bone Marrow-Derived Cells , 2003, Clinical orthopaedics and related research.

[50]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[51]  J. Kohn,et al.  Small changes in polymer chemistry have a large effect on the bone-implant interface: evaluation of a series of degradable tyrosine-derived polycarbonates in bone defects. , 1999, Biomaterials.

[52]  A. Faraj Soft-tissue injury in total knee arthroplasty. , 2002, The Journal of bone and joint surgery. American volume.

[53]  T. Groth,et al.  Altered vitronectin receptor (alphav integrin) function in fibroblasts adhering on hydrophobic glass. , 1999, Journal of biomedical materials research.

[54]  A. Caplan,et al.  Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin. , 1993, The Journal of oral implantology.

[55]  T. Amagasa,et al.  Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[56]  J. Hollinger,et al.  Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). , 1994, Journal of biomedical materials research.

[57]  R. Midura,et al.  Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics , 2003, Journal of biomedicine & biotechnology.

[58]  M. Simon,et al.  Hypoxia‐Inducible Factor and the Development of Stem Cells of the Cardiovascular System , 2001, Stem cells.

[59]  Thomas Mittlmeier,et al.  Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors. , 2002, Journal of neurosurgery.

[60]  I McNiece,et al.  Ex vivo expansion of hematopoietic progenitor cells and mature cells. , 2001, Experimental hematology.

[61]  L G Griffith,et al.  Advances in biomedical engineering. , 2001, JAMA.

[62]  J. Connolly,et al.  Development of an osteogenic bone-marrow preparation. , 1989, The Journal of bone and joint surgery. American volume.

[63]  J H Brekke,et al.  Principles of tissue engineering applied to programmable osteogenesis. , 1998, Journal of biomedical materials research.

[64]  J. W. Strickland,et al.  Flexor tendon repair and rehabilitation: state of the art in 2002. , 2002, Instructional course lectures.

[65]  Burwell Rg,et al.  The function of bone marrow in the incorporation of a bone graft. , 1985 .

[66]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[67]  Linda G Griffith,et al.  Emerging Design Principles in Biomaterials and Scaffolds for Tissue Engineering , 2002, Annals of the New York Academy of Sciences.

[68]  W M Miller,et al.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. , 2001, Biophysical journal.

[69]  D. Shum-Tim,et al.  In vitro preprogramming of marrow stromal cells for myocardial regeneration. , 2002, The Annals of thoracic surgery.

[70]  T. Groth,et al.  Modulating the biocompatibility of polymer surfaces with poly(ethylene glycol): effect of fibronectin. , 2000, Journal of biomedical materials research.

[71]  U. Ripamonti,et al.  Bone Induction by BMPs/OPs and Related Family Members in Primates: The Critical Role of Delivery Systems , 2001, The Journal of bone and joint surgery. American volume.

[72]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[73]  S. Bruder,et al.  Tissue engineering of bone. Cell based strategies. , 1999, Clinical orthopaedics and related research.

[74]  T. Zdeblick,et al.  Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.

[75]  J F Connolly,et al.  Autologous marrow injection as a substitute for operative grafting of tibial nonunions. , 1991, Clinical orthopaedics and related research.

[76]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[77]  A. Grodzinsky,et al.  Transport of tissue inhibitor of metalloproteinases‐1 through cartilage: Contributions of fluid flow and electrical migration , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[78]  W M Miller,et al.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. , 2001, Biophysical journal.

[79]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[80]  M J Yaszemski,et al.  Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. , 1998, Biomaterials.

[81]  C. Boehm,et al.  Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume* , 1997, The Journal of bone and joint surgery. American volume.

[82]  U. Ripamonti,et al.  Bone Differentiation in Porous Hydroxyapatite in Baboons Is Regulated by the Geometry of the Substratum: Implications for Reconstructive Craniofacial Surgery , 1994, Plastic and reconstructive surgery.

[83]  J. Huard,et al.  The Efficiency of Muscle-Derived Cell-Mediated Bone Formation , 2000, Cell transplantation.

[84]  J Reeve,et al.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. , 1980, British medical journal.

[85]  J. Wozney,et al.  Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.

[86]  David Handelsman,et al.  A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. , 2002, The Journal of clinical endocrinology and metabolism.

[87]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[88]  W. Horton,et al.  In vivo cartilage formation from growth factor modulated articular chondrocytes. , 1998, Clinical orthopaedics and related research.

[89]  Nadine Kabbani,et al.  Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.

[90]  T. Groth,et al.  Fibroblast spreading and proliferation on hydrophilic and hydrophobic surfaces is related to tyrosine phosphorylation in focal contacts. , 1995, Journal of biomaterials science. Polymer edition.

[91]  J. Hollinger,et al.  Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. , 1994, Journal of biomedical materials research.

[92]  S. Bonner-Weir,et al.  Number and volume of islets transplanted in immunobarrier devices. , 1998, Cell transplantation.

[93]  C. Rubin,et al.  The use of low-intensity ultrasound to accelerate the healing of fractures. , 2001, The Journal of bone and joint surgery. American volume.

[94]  T. Toth,et al.  Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. , 1998, JAMA.

[95]  A. Reddi,et al.  The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein. , 1992, Matrix.

[96]  A. Grodzinsky,et al.  Contributions of fluid convection and electrical migration to transport in cartilage: relevance to loading. , 1996, Archives of biochemistry and biophysics.

[97]  I. Owan,et al.  Recruitment and proliferative responses of osteoblasts after mechanical loading in vivo determined using sustained-release bromodeoxyuridine. , 1998, Bone.

[98]  T. Jensen,et al.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.

[99]  M. Pittenger,et al.  Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. , 2000, Current topics in microbiology and immunology.

[100]  P. Niederer,et al.  In vivo demonstration of load-induced fluid flow in the rat tibia and its potential implications for processes associated with functional adaptation. , 2000, The Journal of experimental biology.

[101]  Freddie H Fu,et al.  Gene therapy in orthopaedic surgery. , 2002, Instructional course lectures.

[102]  John J. Callaghan,et al.  Osteonecrosis of the Hip: Management in the Twenty-first Century , 2002 .

[103]  H. Genant,et al.  Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. , 1998, The Journal of clinical investigation.

[104]  J. Wei,et al.  Convection and diffusion in tissues and tissue cultures. , 1977, Journal of theoretical biology.

[105]  J. Hubbell,et al.  Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[106]  A. Caplan,et al.  Osteogenesis in Marrow-Derived Mesenchymal Cell Porous Ceramic Composites Transplanted Subcutaneously: Effect of Fibronectin and Laminin on Cell Retention and Rate of Osteogenic Expression , 1992, Cell transplantation.

[107]  R. Midura,et al.  Connective tissue progenitors: practical concepts for clinical applications. , 2002, Clinical orthopaedics and related research.

[108]  D. Kiel,et al.  Growth Hormone Administration and Exercise Effects on Muscle Fiber Type and Diameter in Moderately Frail Older People , 2001, Journal of the American Geriatrics Society.

[109]  Dennis R. Carter,et al.  Mechanobiology of Skeletal Regeneration , 1998, Clinical orthopaedics and related research.

[110]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[111]  S. Kadiyala,et al.  Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. , 1997, Cell transplantation.

[112]  J. Wozney,et al.  Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. , 1996, Plastic and reconstructive surgery.

[113]  S. Pollack,et al.  Signal Transduction in Electrically Stimulated Bone Cells , 2001, The Journal of bone and joint surgery. American volume.

[114]  C. Eaves,et al.  Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. , 1999, Blood.

[115]  V. Goldberg,et al.  Hyaluronic acid‐based polymers as cell carriers for tissue‐engineered repair of bone and cartilage , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[116]  L. Titus,et al.  Mechanism of Bone Formation with Gene Transfer of the cDNA Encoding for the Intracellular Protein LMP-1 , 2003, The Journal of bone and joint surgery. American volume.

[117]  W. Hutton,et al.  Adenoviral Delivery of LIM Mineralization Protein-1 Induces New-Bone Formation in Vitro and in Vivo , 2001, The Journal of bone and joint surgery. American volume.

[118]  A. Caplan,et al.  The establishment of vascular-derived microenvironments in the developing chick wing. , 1983, Developmental biology.

[119]  L. Yahia,et al.  Natural coral exoskeleton as a bone graft substitute: a review. , 2002, Bio-medical materials and engineering.

[120]  Hans Hauner,et al.  Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. , 2003, Arthritis and rheumatism.

[121]  H. Wiesmann,et al.  Periosteally derived osteoblast‐like cells differentiate into chondrocytes in suspension culture in agarose , 2000, The Anatomical record.

[122]  Alan Wells,et al.  Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor , 2001, The Journal of cell biology.

[123]  G. Muschler,et al.  Bone graft materials. An overview of the basic science. , 2000, Clinical orthopaedics and related research.

[124]  J. Connolly,et al.  Autologous Marrow Injection for Delayed Unions of the Tibia: A Preliminary Report , 1989, Journal of orthopaedic trauma.

[125]  T. Ogihara,et al.  Hypoxia Stimulates Release of the Soluble Form of Fas Ligand That Inhibits Endothelial Cell Apoptosis , 2001, Laboratory Investigation.

[126]  R M Neer,et al.  Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25‐dihydroxyvitamin D , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[127]  W M Miller,et al.  Characterization of Hematopoietic Cell Expansion, Oxygen Uptake, and Glycolysis in a Controlled, Stirred‐Tank Bioreactor System , 1998, Biotechnology progress.

[128]  E B Hunziker,et al.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. , 2002, Osteoarthritis and cartilage.

[129]  J. Gimble,et al.  Surface protein characterization of human adipose tissue‐derived stromal cells , 2001, Journal of cellular physiology.

[130]  L G Griffith,et al.  In Vitro Organogenesis of Liver Tissue a , 1997, Annals of the New York Academy of Sciences.

[131]  Min Zhu,et al.  Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow , 2003, Cells Tissues Organs.

[132]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.

[133]  Bartolozzi,et al.  Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors , 2000, British journal of haematology.

[134]  J. Aubin,et al.  Advances in the osteoblast lineage. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[135]  N Nakabayashi,et al.  The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. , 1999, Journal of biomedical materials research.

[136]  F Guilak,et al.  Viscoelastic properties of intervertebral disc cells. Identification of two biomechanically distinct cell populations. , 1999, Spine.

[137]  A Kingman,et al.  In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. , 2001, Biotechnology and bioengineering.

[138]  Cun-Yu Wang,et al.  Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression , 2002, Nature Biotechnology.

[139]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[140]  R Cancedda,et al.  Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.

[141]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[142]  J. Hubbell,et al.  Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. , 2001, Biomacromolecules.

[143]  R. Lindsay,et al.  Parathyroid Hormone Added to Established Hormone Therapy: Effects on Vertebral Fracture and Maintenance of Bone Mass After Parathyroid Hormone Withdrawal , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[144]  J. Lowe,et al.  Metabolic Changes in the Normal and Hypoxic Neonatal Myocardium , 1999, Annals of the New York Academy of Sciences.

[145]  C. Sukenik,et al.  Modulation of fibronectin adhesive functions for fibroblasts and neural cells by chemically derivatized substrata , 1989, Journal of cellular physiology.

[146]  R. McKay Stem cells — hype and hope , 2000, Nature.

[147]  M J Lysaght,et al.  The growth of tissue engineering. , 2001, Tissue engineering.

[148]  S. Bonner-Weir,et al.  In Situ Electrochemical Oxygen Generation with an Immunoisolation Device , 1999, Annals of the New York Academy of Sciences.

[149]  S. Parikh Gene therapy: principles and clinical applications in orthopedics. , 2004, Orthopedics.

[150]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[151]  Philip R. Kuhl,et al.  Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.

[152]  P. Aspenberg,et al.  Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Noninstrumented Posterolateral Lumbar Fusion: 2002 Volvo Award in Clinical Studies , 2002, Spine.

[153]  S. Sharma,et al.  Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. , 1993, Acta orthopaedica Scandinavica.

[154]  Ingo Klimant,et al.  Determination of oxygen gradients in engineered tissue using a fluorescent sensor. , 2002, Biotechnology and bioengineering.